Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and Peripheral Arterial Diseases

cetylpyridinium chloride anhydrous has been researched along with Peripheral Arterial Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thompson, B; Towler, DA1
Anzaldi, M; Fiore, V; Libra, M; Malaponte, G; Neri, S; Puccia, G; Signorelli, SS; Simili, M1

Reviews

1 review(s) available for cetylpyridinium chloride anhydrous and Peripheral Arterial Diseases

ArticleYear
Arterial calcification and bone physiology: role of the bone-vascular axis.
    Nature reviews. Endocrinology, 2012, Volume: 8, Issue:9

    Topics: Atherosclerosis; Blood Vessels; Bone and Bones; Health; Humans; Models, Biological; Peripheral Arterial Disease; Signal Transduction; Vascular Calcification

2012

Other Studies

1 other study(ies) available for cetylpyridinium chloride anhydrous and Peripheral Arterial Diseases

ArticleYear
Patients with unrecognized peripheral arterial disease (PAD) assessed by ankle-brachial index (ABI) present a defined profile of proinflammatory markers compared to healthy subjects.
    Cytokine, 2012, Volume: 59, Issue:2

    Topics: Ankle Brachial Index; Biomarkers; Case-Control Studies; Demography; E-Selectin; Female; Health; Humans; Inflammation Mediators; Interleukin-6; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Peripheral Arterial Disease

2012